These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 779806)

  • 1. Combined immunosuppressive therapy in adult glomerulonephritis.
    Ojeda W; Cangiano JL; Campos JA; González RR; Vázquez J; Muxó OR
    Bol Asoc Med P R; 1976 Jun; 68(6):137-40. PubMed ID: 779806
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
    Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of the treatment of mesangiocapillary glomerulonephritis].
    Rodríguez JA; Olmos A; Ferrer E; Mauri JM; Capdevilla L; Codina S; Alsina J; Camps J; Piera L
    Rev Clin Esp; 1975 Dec; 139(5):415-22. PubMed ID: 1215585
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of glomerulonephritis with corticosteroids and immunosuppressive agents].
    Kampf D; Baethke R
    Dtsch Med Wochenschr; 1974 May; 99(21):1151-6. PubMed ID: 4602084
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis].
    Ponticelli C; Brancaccio D; Locatelli F; Imbasciati E
    Minerva Nefrol; 1969; 16(3):228-34. PubMed ID: 5356052
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment with immunosuppressive agents in disseminated lupus erythematosus and in some evolutive nephropathies].
    Purice S; Ghelerter L; Matei I; Brunazian G
    Stud Cercet Med Interna; 1969; 10(2):147-53. PubMed ID: 5344004
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of primary chronic glomerulonephritis with a triple combination of prednisone, azathioprine and a nitrogen mustard derivative].
    Traver JA; Guajardo DS; Botella J
    Rev Clin Esp; 1975 May; 137(4):321-5. PubMed ID: 1144863
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
    Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
    Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary report on the effects of immunosuppressive therapy with azathioprine in glomerulonephritis].
    Castellani A; Romagnoli GF; Rizzo A; Borsatti A; Gambari PF; Campanacci L
    Minerva Nefrol; 1968; 15(4):219-35. PubMed ID: 5745810
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppressive treatment of glomerulonephritis].
    Attman PO; Bengtsson U
    Lakartidningen; 1975 Apr; 72(16):1663-8. PubMed ID: 1128073
    [No Abstract]   [Full Text] [Related]  

  • 11. [Glomerulonephritis therapy. Immunosuppression or coagulation inhibitors - a comparison].
    Schmitt E; Sinn W; Lakner V; Ratner M; Tomilina N
    Z Gesamte Inn Med; 1980 Aug; 35(15):Suppl 45-8. PubMed ID: 7467565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of primary membranous-proliferative glomerulonephritis].
    Martínez Ara J; Rivero Sánchez M; Miguel Alonso JL; Riñón Aguilar C; Almaraz Jiménez MA; Sanz Guajardo A; Sánchez Sicilia L
    Rev Clin Esp; 1975 Oct; 139(1):61-7. PubMed ID: 1197831
    [No Abstract]   [Full Text] [Related]  

  • 13. Corticosteroid and immunosuppressive treatment in glomerulonephritis. (Literature review).
    Alatas H
    Paediatr Indones; 1974; 14(7-8):135-42. PubMed ID: 4617177
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppressive agents in protein-losing nephritis.
    Black DA
    Sci Basis Med Annu Rev; 1970; ():113-30. PubMed ID: 4920175
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of chronic glomerulopathy].
    Orlowski T; Gradowska L; Lao M; Rancewicz Z; Rowinska D
    Z Gesamte Inn Med; 1972 Nov; 27(22):980-3. PubMed ID: 4649659
    [No Abstract]   [Full Text] [Related]  

  • 16. [On immunosuppressive therapy of primary nephrotic syndrome in the pediatric age].
    Varese LA
    Minerva Pediatr; 1971 Dec; 23(50):2090-102. PubMed ID: 5135685
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV; Holley KE; Ilstrup DM
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of the nephrotic syndrome.
    Linshaw MA; Gruskin AB
    Clin Pediatr (Phila); 1974 Jan; 13(1):45-51. PubMed ID: 4588668
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunosuppressive therapy (cytostatics) in glomerulonephritis].
    Ricken D
    Verh Dtsch Ges Inn Med; 1972; 78():766-70. PubMed ID: 4665751
    [No Abstract]   [Full Text] [Related]  

  • 20. "Immunosuppressive" treatment of "chronic glomerulonephritis".
    Kallen RJ; Lewis EJ
    J Pediatr; 1973 Feb; 82(2):335-9. PubMed ID: 4567554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.